Без стеснения. Все о чудесном женском теле

23. Philipp Т., Philipp K., Reiner A., Beer R, Kalousek D.K. Embryoscopic and cytogenetic analysis of 233 missed abortions: factors involved in the pathogenesis of developmental defects of early failed pregnancies // Hum Reprod. 2003. Vol. 18. P. 1724–1732.

24. Macklon N.S., Geraedts J.P., Fauser B.C. Conception to ongoing pregnancy: the «black box» of early pregnancy loss // Hum Reprod Update. 2002. Vol. 8. P. 333–343.

25. Nybo Andersen A.M., Wohlfahrt J., Christens P., Olsen J., Melbye M. Maternal age and fetal loss: population based register linkage study// BMJ. 2000. Vol. 320. P. 1708–1712.

26. Lagranha C.J., Silva T.L. A, Silva S.C. A., Braz G.R. R, da Silva A.I., Fer-nandes M.P, Sellitti D.F. Protective effects of estrogen against cardiovascular disease mediated via oxidative stress in the brain // Life Sci. 2018 Jan 1. Vol. 192. P. 190–198.

27. Green PS., Simpkins J.W. Neuroprotective effects of estrogens: potential mechanisms of action // Int J Dev Neurosci. 2000 Jul-Aug. Vol. 18(4–5). P. 347–358.

28. Backstrom Т., Sanders D., Leask R., Davidson D., Warner P., Bancroft J. Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome // Psychosom Med. 1983 Dec. Vol. 45(6). P. 503–507.

29. Roney J.R., Simmons Z.L. Hormonal predictors of sexual motivation in natural menstrual cycles // Horm Behav. 2013 Apr. Vol. 63(4). P. 636–645.

30. Roney J.R., Simmons Z.L. Within-cycle fluctuations in progesterone negatively predict changes in both in-pair and extra-pair desire among partnered women // Horm Behav. 2016 May. Vol. 81. P. 45–52.

31. Roney J.R., Simmons Z.L. Ovarian hormone fluctuations predict within-cycle shifts in women's food intake//Horm Behav. 2017 Apr. Vol. 90. P. 8–14.

32. Yamazaki M., Tamura K. The menstrual cycle affects recognition of emotional expressions: an event-related potential study // F1 OOORes. 2017 Jun 8. Vol. 6. P. 853.

33. Ryu A., Kim Т.Н. Premenstrual syndrome: A mini review//Maturitas. 2015 Dec. Vol. 82(4). P. 436–440.

34. Jarvis С.I., Lynch A. M., Morin A. K. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder // Ann Pharmacother. 2008 Jul. Vol. 42(7). P. 967–978.

35. Bahrami A., Avan A., Sadeghnia H. R., Esmaeili H., Tayefi M., Ghasemi R, Nejati Salehkhani R, Arabpour-Dahoue M., Rastgar-Moghadam A., Ferns G.A., Bahrami-Taghanaki H., Ghayour-Mobarhan M. High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents // Gynecol Endocrinol. 2018 Feb 15. P. 1–5.

36. Bertone-Johnson E. R., Ronnenberg A. G., Houghton S. C., Nobles C, Zagarins S. E., Takashima-Uebelhoer B.B., Faraj J. L., Whitcomb B. W. Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women // Hum Reprod. 2014 Sep. Vol. 29(9). P. 1987–1994.

37. Gillings, Michael R. Were there evolutionary advantages to premenstrual syndrome? // Evol Appl. 2014 Sep. Vol. 7(8). P. 897–904.

38. Rossouw J.E., Anderson G.L., Prentice R.L. et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin inhealthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial // JAMA. 2002. Vol. 288(3). P. 321–333.

39. Anderson G.L., Limacher M., Assaf A.R., Bassford Т., Beresford S.A., Black H., Bonds D., Brunner R., Brzyski R., Caan В., Chlebowski R., Curb D., Gass M., Hays J., Heiss G., Hendrix S., Howard B.V., Hsia J., Hubbell A., Jackson R., Johnson K.C., Judd H., Kotchen J.M., Kuller L., LaCroix A.Z., Lane D., Langer R.D., Lasser N., Lewis C.E., Manson J., Margolis K., Ockene J., O'Sullivan M.J., Phillips L, Prentice R.L., Ritenbaugh C, Rob-bins J., Rossouw J.E., Sarto G., Stefanick M.L., Van Horn L., Wactawski-Wende J., Wallace R., Wassertheil-Smoller S. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial // JAMA. 2004 Apr 14. Vol. 291 (14). P. 1701–1712.

40. Chen W.Y., Rosner В., Hankinson S.E., Colditz G.A., Willett W.C. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk // JAMA. 2011 Nov 2. Vol. 306(17). P. 1884–1890.

41. Andrew M. Kaunitz and JoAnn E. Manson. Management of Menopausal Symptoms // Obstet Gynecol. 2015 Oct. Vol. 126(4). P. 859–876.

42. Manson J.E., Kaunitz A.M. Menopause Management-Getting Clinical Care Back on Track// N Engl J Med. 2016 Mar 3. Vol. 374(9). P. 803–806.

43. Mikkola T.S., Savolainen-Peltonen H., Tuomikoski P., Hoti R, Vattulainen P., Gissler M., Ylikorkala O. Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study//Menopause. 2016 Nov. Vol. 23(11). P. 1199–1203.